These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 14999363)

  • 21. Anti-HIV and Anti-Hepatitis C Virus Drugs Inhibit P-Glycoprotein Efflux Activity in Caco-2 Cells and Precision-Cut Rat and Human Intestinal Slices.
    Martinec O; Huliciak M; Staud F; Cecka F; Vokral I; Cerveny L
    Antimicrob Agents Chemother; 2019 Nov; 63(11):. PubMed ID: 31481446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Human organic anion-transporting polypeptide OATP-A (SLC21A3) acts in concert with P-glycoprotein and multidrug resistance protein 2 in the vectorial transport of Saquinavir in Hep G2 cells.
    Su Y; Zhang X; Sinko PJ
    Mol Pharm; 2004 Jan; 1(1):49-56. PubMed ID: 15832500
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Targeting SVCT for enhanced drug absorption: synthesis and in vitro evaluation of a novel vitamin C conjugated prodrug of saquinavir.
    Luo S; Wang Z; Patel M; Khurana V; Zhu X; Pal D; Mitra AK
    Int J Pharm; 2011 Jul; 414(1-2):77-85. PubMed ID: 21571053
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic interactions between 20(S)-ginsenoside Rh2 and the HIV protease inhibitor ritonavir in vitro and in vivo.
    Shi J; Cao B; Zha WB; Wu XL; Liu LS; Xiao WJ; Gu RR; Sun RB; Yu XY; Zheng T; Li MJ; Wang XW; Zhou J; Mao Y; Ge C; Ma T; Xia WJ; Aa JY; Wang GJ; Liu CX
    Acta Pharmacol Sin; 2013 Oct; 34(10):1349-58. PubMed ID: 23892274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Influence of atazanavir 200 mg on the intracellular and plasma pharmacokinetics of saquinavir and ritonavir 1600/100 mg administered once daily in HIV-infected patients.
    Ford J; Boffito M; Maitland D; Hill A; Back D; Khoo S; Nelson M; Moyle G; Gazzard B; Pozniak A
    J Antimicrob Chemother; 2006 Nov; 58(5):1009-16. PubMed ID: 16984898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Involvement of P-glycoprotein in the transport of saquinavir and indinavir in rat brain microvessel endothelial and microglia cell lines.
    Ronaldson PT; Lee G; Dallas S; Bendayan R
    Pharm Res; 2004 May; 21(5):811-8. PubMed ID: 15180339
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Unmasking the dynamic interplay between intestinal P-glycoprotein and CYP3A4.
    Cummins CL; Jacobsen W; Benet LZ
    J Pharmacol Exp Ther; 2002 Mar; 300(3):1036-45. PubMed ID: 11861813
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combination of protease inhibitors for the treatment of HIV-1-infected patients: a review of pharmacokinetics and clinical experience.
    van Heeswijk RP; Veldkamp A; Mulder JW; Meenhorst PL; Lange JM; Beijnen JH; Hoetelmans RM
    Antivir Ther; 2001 Dec; 6(4):201-29. PubMed ID: 11878403
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HIV-protease inhibitors contribute to P-glycoprotein efflux function defect in peripheral blood lymphocytes from HIV-positive patients receiving HAART.
    Lucia MB; Rutella S; Leone G; Vella S; Cauda R
    J Acquir Immune Defic Syndr; 2001 Aug; 27(4):321-30. PubMed ID: 11468419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of aged garlic extract on the uptake of saquinavir and darunavir into HepG2 cells and rat liver slices.
    Berginc K; Trontelj J; Kristl A
    Drug Metab Pharmacokinet; 2010; 25(3):307-13. PubMed ID: 20610890
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effects of grapefruit juice and orange juice components on P-glycoprotein- and MRP2-mediated drug efflux.
    Honda Y; Ushigome F; Koyabu N; Morimoto S; Shoyama Y; Uchiumi T; Kuwano M; Ohtani H; Sawada Y
    Br J Pharmacol; 2004 Dec; 143(7):856-64. PubMed ID: 15504753
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HIV protease inhibitors, saquinavir, indinavir and ritonavir: inhibition of CYP3A4-mediated metabolism of testosterone and benzoxazinorifamycin, KRM-1648, in human liver microsomes.
    Inaba T; Fischer NE; Riddick DS; Stewart DJ; Hidaka T
    Toxicol Lett; 1997 Dec; 93(2-3):215-9. PubMed ID: 9486958
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Assessment of active transport of HIV protease inhibitors in various cell lines and the in vitro blood--brain barrier.
    van der Sandt IC; Vos CM; Nabulsi L; Blom-Roosemalen MC; Voorwinden HH; de Boer AG; Breimer DD
    AIDS; 2001 Mar; 15(4):483-91. PubMed ID: 11242145
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of Ginkgo biloba extract on lopinavir, midazolam and fexofenadine pharmacokinetics in healthy subjects.
    Robertson SM; Davey RT; Voell J; Formentini E; Alfaro RM; Penzak SR
    Curr Med Res Opin; 2008 Feb; 24(2):591-9. PubMed ID: 18205997
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
    Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
    Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of vinblastine efflux mediated by P-glycoprotein by grapefruit juice components in caco-2 cells.
    Takanaga H; Ohnishi A; Matsuo H; Sawada Y
    Biol Pharm Bull; 1998 Oct; 21(10):1062-6. PubMed ID: 9821810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New insights into drug absorption: studies with sirolimus.
    Paine MF; Leung LY; Watkins PB
    Ther Drug Monit; 2004 Oct; 26(5):463-7. PubMed ID: 15385826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Interaction of ritonavir on tissue distribution of a [(14)c]L-valinamide, a potent human immunodeficiency virus-1 protease inhibitor, in rats using quantitative whole-body autoradiography.
    Solon EG; Balani SK; Luo G; Yang TJ; Haines PJ; Wang L; Demond T; Diamond S; Christ DD; Gan LS; Lee FW
    Drug Metab Dispos; 2002 Nov; 30(11):1164-9. PubMed ID: 12386120
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Circumventing P-glycoprotein-mediated cellular efflux of quinidine by prodrug derivatization.
    Jain R; Majumdar S; Nashed Y; Pal D; Mitra AK
    Mol Pharm; 2004; 1(4):290-9. PubMed ID: 15981588
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Selective biotransformation of the human immunodeficiency virus protease inhibitor saquinavir by human small-intestinal cytochrome P4503A4: potential contribution to high first-pass metabolism.
    Fitzsimmons ME; Collins JM
    Drug Metab Dispos; 1997 Feb; 25(2):256-66. PubMed ID: 9029057
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.